Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,619.52
    -562.22 (-1.08%)
     
  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $7.8 Billion by 2030

ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, March 15, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Industry" - https://www.reportlinker.com/p06361342/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $7.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$4.6 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at aCAGR of 6.7% over the period 2022-2030. Hemostats, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Internal Tissue Sealants segment is readjusted to a revised 6.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 11.3% CAGR

The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Select Competitors (Total 44 Featured)
- Axio Biosolutions Private Limited
- Beacon Senior Advisors
- Chitogen, Inc.
- Corlison Pte. Limited
- Ethicon US LLC
- GELITA MEDICAL
- LifeBond Ltd.
- Tissuemed Ltd.


Read the full report: https://www.reportlinker.com/p06361342/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Surgical Hemostats, Internal Tissue Sealants, and Adhesion
Barriers - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Hemostats by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Hemostats by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Hemostats by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Internal Tissue Sealants by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Internal Tissue Sealants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Internal Tissue Sealants
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Adhesion Barriers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Adhesion Barriers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Adhesion Barriers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Surgical Repair Applications by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Surgical Repair
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Surgical Repair
Applications by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Trauma Cases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Trauma Cases by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Trauma Cases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Specialty Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Specialty Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 24: World 16-Year Perspective for Specialty Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 25: World Surgical Hemostats, Internal Tissue Sealants
and Adhesion Barriers Market Analysis of Annual Sales in US$
Million for Years 2014 through 2030

Table 26: World Recent Past, Current & Future Analysis for
Ambulatory Surgery Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 27: World Historic Review for Ambulatory Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 28: World 16-Year Perspective for Ambulatory Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

III. MARKET ANALYSIS

UNITED STATES
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 32: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 33: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Application - Surgical
Repair Applications and Trauma Cases Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 34: USA 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 35: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by End-Use - Hospitals,
Ambulatory Surgery Centers and Specialty Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 39: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 40: Canada 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 41: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 42: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 44: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 46: Canada 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

JAPAN
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 48: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 49: Japan 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 50: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 51: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 53: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 54: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 55: Japan 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

CHINA
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 58: China 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 59: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 60: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 62: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 63: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 64: China 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

EUROPE
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 66: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 67: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - Percentage Breakdown of Value Sales for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2014, 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 71: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 72: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

FRANCE
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 78: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 79: France 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 80: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 81: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 83: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 85: France 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

GERMANY
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 88: Germany 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 89: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 90: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 92: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 94: Germany 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 96: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 97: Italy 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 98: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 99: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 101: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 102: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 103: Italy 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2014, 2023 &
2030

UNITED KINGDOM
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 105: UK Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 106: UK 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2014, 2023 &
2030

Table 107: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 108: UK Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Application - Surgical
Repair Applications and Trauma Cases Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 109: UK 16-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2014, 2023 & 2030

Table 110: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06361342/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001